Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV?

Rowan PJ.

World J Virol. 2013 Nov 12;2(4):139-45. doi: 10.5501/wjv.v2.i4.139. Review.

2.

CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.

Klein MB, Cooper C, Brouillette MJ, Sheehan NL, Benkelfat C, Annable L, Weston F, Kraus D, Singer J; CTN194 Investigators.

Contemp Clin Trials. 2008 Jul;29(4):617-30. doi: 10.1016/j.cct.2008.01.001. Epub 2008 Jan 12.

PMID:
18262853
3.

A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.

Morasco BJ, Rifai MA, Loftis JM, Indest DW, Moles JK, Hauser P.

J Affect Disord. 2007 Nov;103(1-3):83-90. Epub 2007 Feb 9. Erratum in: J Affect Disord. 2009 Feb;113(1-2):201.

PMID:
17292481
4.

Can antidepressants prevent interferon-alpha-induced depression? A review of the literature.

Galvão-de Almeida A, Guindalini C, Batista-Neves S, de Oliveira IR, Miranda-Scippa A, Quarantini LC.

Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):401-5. doi: 10.1016/j.genhosppsych.2010.03.001. Epub 2010 Apr 2. Review.

PMID:
20633744
5.
6.

Interferon alpha for chronic hepatitis D.

Abbas Z, Khan MA, Salih M, Jafri W.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006002. doi: 10.1002/14651858.CD006002.pub2. Review.

PMID:
22161394
7.

Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.

Ogawa E, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J; Kyushu University Liver Disease Study [KULDS] Group.

J Gastroenterol Hepatol. 2012 Jul;27(7):1233-40. doi: 10.1111/j.1440-1746.2011.06965.x.

PMID:
22098185
8.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

9.

[Reflections on the treatment of EDM in hepatitis C virus patients treated with interferon alpha from a retrospective survey concerning 29 patients].

Lang JP, Halleguen O, Vecchionacci V, Doffoel M.

Encephale. 2003 May-Jun;29(3 Pt 1):273-7. French.

PMID:
12876553
10.
11.

Strategies for managing sexual dysfunction induced by antidepressant medication.

Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K.

Cochrane Database Syst Rev. 2013 May 31;5:CD003382. doi: 10.1002/14651858.CD003382.pub3. Review.

PMID:
23728643
12.

Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(7):1-98. Epub 2004 Jun 1.

13.

[Interest of the use of pindolol in the treatment of depression: review].

Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.

Encephale. 2003 Jul-Aug;29(4 Pt 1):338-50. Review. French.

PMID:
14615704
14.

Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin.

Carriero D, Fabrizi F, Uriel AJ, Park J, Martin P, Dieterich DT.

Int J Artif Organs. 2008 Apr;31(4):295-302.

PMID:
18432584
15.

Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus.

Iorio A, Marchesini E, Awad T, Gluud LL.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004888. doi: 10.1002/14651858.CD004888.pub2. Review.

PMID:
20091566
16.

Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.

Piccinino F, Felaco FM, Sagnelli E, Aprea L, Messina V, Pasquale G, Filippini P, Scolastico C.

Res Virol. 1998 Sep-Oct;149(5):283-91.

PMID:
9879606
17.

Equally poor outcomes to pegylated interferon-based therapy in African Americans and Hispanics with chronic hepatitis C infection.

Satapathy SK, Lingisetty CS, Proper S, Chaudhari S, Williams S.

J Clin Gastroenterol. 2010 Feb;44(2):140-5. doi: 10.1097/MCG.0b013e3181ba9992.

PMID:
19826275
18.

Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review.

Nelligan JA, Loftis JM, Matthews AM, Zucker BL, Linke AM, Hauser P.

J Clin Psychiatry. 2008 May;69(5):810-6. Review.

PMID:
18426262
19.

Treatment of depression--newer pharmacotherapies.

Mulrow CD, Williams JW Jr, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noël PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K.

Psychopharmacol Bull. 1998;34(4):409-795. Review.

PMID:
10513454
20.

[Managing psychiatric side effects of antiviral therapy in chronic hepatitis C].

Schäfer A, Scheurlen M, Kraus MR.

Z Gastroenterol. 2012 Oct;50(10):1108-13. doi: 10.1055/s-0031-1281682. Epub 2012 Oct 11. Review. German.

PMID:
23059806
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk